In July 2011, the U.S. Food and Drug Administration (FDA) requested revision to the product label for the antipsychotic drug quetiapine (SEROQUEL and SEROQUEL XL) to warn against use with certain classes of drugs known to cause an arrhythmia, or...
Darvon & Darvocet Recalled for Potentially Fatal Heart Damage
Following communications with the Food and Drug Administration (FDA), Xanodyne Pharmaceuticals has initiated a voluntary recall of 2 prescription pain killers because of a risk of serious heart damage that could result in death. The 2 drugs in...
Warning: Pradaxa Linked to Increased Risk of Heart Attack
Boehringer Ingelheim’s Pradaxa is a new blood clot preventer, which is an alternative to half a century old warfarin. Pradaxa, chemically known as dabigatran, has been approved in the United States in October 2010 for stroke prevention in...